Skip to main content
. 2021 Jan 12;22(2):710. doi: 10.3390/ijms22020710
24(S)-HC 24(S)-hydroxycholesterol
25-HC 25-hydroxycholesterol
3-MA 3-Methyladenine
AD Alzheimer’s disease
ALS Amyotrophic lateral sclerosis
AMPAR AMPA-receptor
AMPK AMP-activated protein kinase
Apo E Apolipoprotein E
APP Amyloid precursor protein
Cas CRISPR-associated gene
CBZ Carbamazepine
CD Cyclodextrin
CNS Central nervous system
CoQ10 Coenzyme Q10
cPCs Cerebellar Purkinje cells
CRISPR Clustered regularly interspaced short palindromic repeats
ER Endoplasmic reticulum
GABAAR GABAA receptor
GD Gaucher’s Disease
GFAP Glial fibrillary acidic protein
GlyR Glycine receptor
HAT Histone acetyl transferase
HDACi Histone deacetylase inhibitor
hESC Human embryonic stem cell
Hex A Hexosaminidase A
HLC Hepatocyte-like cell
hSKIN-MASCS Human skin multipotent adult stem cells
HP-α-CD Hydroxypropyl-alpha-cyclodextrin
HP-β-CD Hydroxypropyl-beta-cyclodextrin
HP-γ-CD Hydroxypropyl-gamma-cyclodextrin
HSEM Horizontal saccadic eye movement
iPSC Induced pluripotent stem cell
KD Knock down
LC3B Microtubule-associated protein a light chain 3B
LE/LY Late endosome/lysosome
LSD Lysosomal storage disorder
M-β-CD Methyl-beta-cyclodextrin
NDCs Neuronal differentiated cells
NPC Neural progenitor cell
NPC1 Niemann-Pick type C1
NPC2 Niemann-Pick type C2
NSS Neurological Severity Scores
OS Oxidative stress
PC Pharmacological chaperone
PD Parkinson’s disease
PMA Phorbol 12-myristate 13-acetate
PSCs Pluripotent stem cells
Rap Rapamycin
RIP1/3 Receptor interacting protein kinase 1/3
ROS Reactive oxygen species
S1P Sphingosine-1-phosphate
SAHA Suberanilohydroxamic acid
SOD Superoxide-Dismutase
SphK Sphingosine kinase
SRT Substrate reduction therapy
TALEN Transcription activator-like effector nuclease
Tre Trehalose
VEGF Vascular endothelial growth factor
Ver Verapamil
VSGP Vertical supranuclear gaze palsy